VBI Vaccines Inc (VBIVQ)
followers
·
Follow
| Sector: | MATERIALS |
| Industry: | GOLD & SILVER |
| SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| CEO: | Jeffrey R. Baxter |
| Employees: | 22 |
| Web site: | www.vbivaccines.com |
|
222 THIRD STREET, SUITE 2241, CAMBRIDGE, MA, 02142
6178303031
| |
| Date | Ratio |
|---|---|
| 2016-05-02 | 1:40 |
| 2023-04-12 | 1:30 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
VBI Vaccines Inc. develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for chronic HBV infection.
Please log in first to see chart